Drugs targeting macrophage related markers such as CSF-1, IFN-γ, VEGF, chemokines, and cell surface antigens are being gradually put into trials, and are one of the future research focuses of tumor immunotherapy targeting macrophages (19). Here, IFNG is linked to neoplasm.